Printer Friendly

ALPHA-BETA TECHNOLOGY FILES REGISTRATION STATEMENT WITH SEC FOR PUBLIC OFFERING OF 1,300,000 SHARES OF COMMON STOCK

 WORCESTER, Mass., Nov. 1 /PRNewswire/ -- Alpha-Beta Technology, Inc. (NASDAQ: ABTI) today announced that it has filed a registration statement with the Securities and Exchange Commission relating to a public offering of 1,300,000 shares of its common stock. Alex. Brown & Sons Incorporated, Vector Securities International, Inc. and Kidder, Peabody & Co., Incorporated will manage the offering.
 Alpha-Beta Technology, Inc. is developing a novel class of proprietary pharmaceutical products composed of complex carbohydrates. The company's therapeutic products are designed to prevent and treat infection and certain inflammatory diseases and to reduce cholesterol. The company's lead product, Betafectin(TM), is a proprietary carbohydrate immunotherapeutic targeted for the prevention and treatment of infection.
 Alpha-Beta will grant the underwriters an option to purchase an additional 195,000 shares of common stock solely to cover over-allotments, if any.
 A copy of the preliminary prospectus may be obtained from the prospectus departments of the managing underwriters: Alex. Brown & Sons Incorporated, 135 East Baltimore St., Baltimore, MD 21202; Vector Securities International, Inc., 1751 Lake Cook Rd., Suite 350, Deerfield, IL 60015; Kidder, Peabody & Co., Incorporated, 60 Broad St. (6th floor), New York, NY 10004.
 A registration statement relating to these securities has been filed with the Securities and Exchange Commission, but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
 -0- 11/1/93
 /CONTACT: Braden M. Bohrmann, Chief Financial Officer of Alpha-Beta Technology, 508-798-6900; or Robert Gottlieb, Senior Vice President of Feinstein Partners, 617-577-8110 for Alpha-Beta Technology/
 (ABTI)


CO: Alpha-Beta Technology, Inc. ST: Massachusetts IN: MTC SU: OFR

DJ -- NE006 -- 9041 11/01/93 10:10 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 1, 1993
Words:332
Previous Article:INNOVEX DECLARES QUARTERLY DIVIDEND
Next Article:CELL GENESYS FILES FOR STOCK OFFERING
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters